An Automated Grading System for Detection of Vision-Threatening Referable Diabetic Retinopathy on the Basis of Color Fundus Photographs

Author:

Li Zhixi1,Keel Stuart2,Liu Chi3,He Yifan3,Meng Wei3,Scheetz Jane2,Lee Pei Ying2,Shaw Jonathan4,Ting Daniel5,Wong Tien Yin5,Taylor Hugh6,Chang Robert7,He Mingguang12ORCID

Affiliation:

1. State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China

2. Centre for Eye Research Australia, University of Melbourne, Melbourne, Australia

3. Guangzhou Healgoo Interactive Medical Technology Co. Ltd., Guangzhou, China

4. Baker Heart and Diabetes Institute, Melbourne, Australia

5. Singapore Eye Research Institute, Singapore National Eye Centre, Duke-NUS Medical School, National University of Singapore, Singapore

6. Indigenous Eye Health Unit, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Australia

7. Department of Ophthalmology, Byers Eye Institute, Stanford University, Palo Alto, CA

Abstract

OBJECTIVE The goal of this study was to describe the development and validation of an artificial intelligence–based, deep learning algorithm (DLA) for the detection of referable diabetic retinopathy (DR). RESEARCH DESIGN AND METHODS A DLA using a convolutional neural network was developed for automated detection of vision-threatening referable DR (preproliferative DR or worse, diabetic macular edema, or both). The DLA was tested by using a set of 106,244 nonstereoscopic retinal images. A panel of ophthalmologists graded DR severity in retinal photographs included in the development and internal validation data sets (n = 71,043); a reference standard grading was assigned once three graders achieved consistent grading outcomes. For external validation, we tested our DLA using 35,201 images of 14,520 eyes (904 eyes with any DR; 401 eyes with vision-threatening referable DR) from population-based cohorts of Malays, Caucasian Australians, and Indigenous Australians. RESULTS Among the 71,043 retinal images in the training and validation data sets, 12,329 showed vision-threatening referable DR. In the internal validation data set, the area under the curve (AUC), sensitivity, and specificity of the DLA for vision-threatening referable DR were 0.989, 97.0%, and 91.4%, respectively. Testing against the independent, multiethnic data set achieved an AUC, sensitivity, and specificity of 0.955, 92.5%, and 98.5%, respectively. Among false-positive cases, 85.6% were due to a misclassification of mild or moderate DR. Undetected intraretinal microvascular abnormalities accounted for 77.3% of all false-negative cases. CONCLUSIONS This artificial intelligence–based DLA can be used with high accuracy in the detection of vision-threatening referable DR in retinal images. This technology offers potential to increase the efficiency and accessibility of DR screening programs.

Funder

National Natural Science Foundation of China

Science and Technology Planning Project

Bupa Health Foundation

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference40 articles.

1. Global prevalence and major risk factors of diabetic retinopathy;Yau;Diabetes Care,2012

2. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants;NCD Risk Factor Collaboration (NCD-RisC);Lancet,2016

3. International Diabetes Federation. IDF Diabetes Atlas, 7th edition [Internet], 2015. Available from http://www.diabetesatlas.org. Accessed 10 November 2017

4. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review;Ting;Clin Experiment Ophthalmol,2016

5. Diabetic retinopathy;Cheung;Lancet,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3